Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

epiCRISPR Citations (7)

Originally described in: An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells.
Xie Y, Wang D, Lan F, Wei G, Ni T, Chai R, Liu D, Hu S, Li M, Li D, Wang H, Wang Y Sci Rep. 2017 May 24;7(1):2320. doi: 10.1038/s41598-017-02456-y. PubMed Journal

Articles Citing epiCRISPR

Articles
CRISPR/Cas9 mediated establishment of a human CSRP3 compound heterozygous knockout hESC line to model cardiomyopathy and heart failure. Sun L, Li J, Li E, Niu S, Qin Z, Zhi Q, Zhao J, Xiong H, Li Y, Jian L, Zhang L. Stem Cell Res. 2020 Dec;49:102077. doi: 10.1016/j.scr.2020.102077. Epub 2020 Nov 4. PubMed
Establishment of a human MYH6 compound heterozygous knockout hESC line to model cardiomyopathy and congenital heart defects by CRISPR/Cas9 system. Hao E, Zhang G, Mu L, Ma N, Wang T. Stem Cell Res. 2020 Dec 16;50:102128. doi: 10.1016/j.scr.2020.102128. PubMed
Establishment of a KCNQ1 homozygous knockout human embryonic stem cell line by episomal vector-based CRISPR/Cas9 system. Liu X, Zhang S, Chang Y, Wu F, Bai R. Stem Cell Res. 2021 Aug;55:102467. doi: 10.1016/j.scr.2021.102467. Epub 2021 Jul 22. PubMed
A CRISPR/Cas9 strategy for the generation of a FLNC knockout hESC line (WAe009-A-70) to model dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy. Qin Z, Sun L, Sun X, Su H, Gao X. Stem Cell Res. 2021 Oct;56:102562. doi: 10.1016/j.scr.2021.102562. Epub 2021 Oct 7. PubMed
Generation of a TRPM8 knockout hESC line (WAe009-A-A) derived from H9 using CRISPR/Cas9. Bai J, Zhang J, Fu W, Li S, Tian X, Li X, Zhao X, Dong J. Stem Cell Res. 2023 Mar;67:103040. doi: 10.1016/j.scr.2023.103040. Epub 2023 Feb 6. PubMed
Generation of a FLNA knockout hESC line (WAe009-A-P) to model cardiac valvular dysplasia using CRISPR/Cas9. Lu F, Gao Y, Li E. Stem Cell Res. 2023 Jul 1;71:103162. doi: 10.1016/j.scr.2023.103162. PubMed
Generation of a TAB2 knockout hESC line (WAe009-A-Z) derived from H9 using CRISPR/Cas9. Sun W, Li X, Dong J, Zhou Y. Stem Cell Res. 2024 Feb;74:103284. doi: 10.1016/j.scr.2023.103284. Epub 2023 Dec 16. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.